Microglia-targeted delivery of MCC950 suppresses NLRP3–IL-18-mediated neuroinflammation and retinal injury in retinal vein occlusion
Retinal vein occlusion (RVO) causes retinal ischemia, macular edema, and vision loss, yet current anti-vascular endothelial growth factor (anti-VEGF) therapies primarily limit vascular leakage and leave ischemia-driven neuroinflammation insufficiently controlled. Here, we reveal a critical role for microglia-associated...